Weipu Mao

6PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2025
CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3.

Houliang Zhang, Tao Tao, Jie Ji

|Jul 07, 2025
YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Wenchao Li, SaiSai Chen, Jian Lu

|Nov 04, 2024
Research progress of MUC1 in genitourinary cancers.

Weipu Mao, Houliang Zhang, Keyi Wang

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Nov 27, 2023
Cisplatin induces acute kidney injury by downregulating miR-30e-5p that targets Galnt3 to activate the AMPK signaling pathway.

Weipu Mao, Lei Zhang, Yiduo Wang

|Jun 23, 2022
Noncoding-RNA mediated high expression of zinc finger protein 268 suppresses clear cell renal cell carcinoma progression by promoting apoptosis and regulating immune cell infiltration.

Keyi Wang, Yongzhe Gu, Jinliang Ni

Pageof 1

Frequent Collaborators

2 joint publications

Keyi Wang

1 joint publications

Yongzhe Gu

1 joint publications

Jinliang Ni

1 joint publications

Houliang Zhang